Viewing Study NCT03982303


Ignite Creation Date: 2025-12-24 @ 7:49 PM
Ignite Modification Date: 2026-02-22 @ 12:23 PM
Study NCT ID: NCT03982303
Status: UNKNOWN
Last Update Posted: 2021-10-01
First Post: 2019-06-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study of Hemay102 in Patients With Advanced Solid Tumors
Sponsor: Tianjin Hemay Oncology Pharmaceutical Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module